Purpose of the APW (Objective)
To provide expert technical recommendations on a Monitoring and Evaluation (M&E) Framework for the Measles Rubella Strategic Framework (MRSF) that is based on best practice, feasible for countries, aligned with the M&E framework of Immunization
Agenda 2030 (IA2030) and the Measles Outbreak Strategic Response Plan (MOSRP), and supports integration and strengthening of routine immunization across all essential immunization programmes.
Background
The mission of the Department of Immunization, Vaccines and Biologicals (IVB) is to work towards a world in which all people are vaccinated against vaccine-preventable diseases. Measles and rubella (MR)
are a high impact cross cutting priority for IVB as well as a priority for donors and partners in the Measles and Rubella Initiative (M&RI). Globally, coverage of the first dose of measles containing vaccine (MCV1) has not improved for a decade,
and the SARS-CoV2 pandemic has further disrupted both routine immunization and campaigns increasing the risk of outbreaks. In this context, deliverables from this activity will support the World Health Organization (WHO)’s technical partners
and ministries of health in providing evaluation and monitoring tools to support the implementation of key global strategies including IA2030, MRSF and MOSRP.
Work to be performed
The service provider will need to achieve the following outputs:
Output 1: Synthesize M&E Frameworks relevant to MR.
Output 2: Develop a MRSF M&E framework and an implementation plan.
Output 3: Develop and support a consultation process on the MRSF M&E Framework.
Output 4: Map MR eradication benchmarking milestones derived from modelling to the draft MRSF M&E framework and provide recommendation on which milestones should be incorporated into the MRSF M&E.
Deliverables
| Deliverables for Output 1 | Dates due |
|---|---|
| D1. Provide a report on M&E frameworks including for IA2030 and for other priority disease-specific areas, and with consideration of potential for tracking integration and promoting partnerships across other disease-specific
initiatives (Yellow Fever, etc). Estimated effort: ~maximum 10 days total | 31-07-2021 |
| D2. Develop a synthesis of existing Measles and Rubella M&E indicators, map these to the MRSF strategic priorities and prioritize. Estimated effort: ~maximum 10 days total | 31-07-2021 |
| Deliverables for Output 2 | |
| D3. Provide expert advice on the optimal design of the MRSF M&E framework taking into account evidence on best practice for global health strategy M&E and including recommendations on reporting processes (for accountability)
and flexibility for M&E to adapt and evolve (e.g. to incorporate benchmarking towards eradication). Estimated effort: ~maximum 10 days total | 31-08-2021 |
| D4. Develop a consultation plan for a MRSF M&E framework including consideration of global priorities on zero-dose children and campaigns, global, regional and country. perspectives. Estimated effort: ~maximum 10 days total | 30-09-2021 |
| Deliverables for Output 3 | |
| D5. Refine MRSF M&E based on virtual regional and country consultation. Estimated effort: ~maximum 10 days total | 31-10-2021 |
| D6. Support final consultation on MRSF M&E and advice on processes for adaptation and accountability mechanisms. Estimated effort: ~maximum 10 days total | 30-11-2021 |
| Deliverables for Output 4 | |
| D7. Provide a report summarizing potential eradication milestones working with WHO Headquarters (HQ) staff and modellers and map to MRSF M&E. Estimated effort: ~maximum 10 days total | 30-09-2021 |
| D8. Conceptualize and help plan a consultation on MR eradication benchmarking and MRSF M&E with WHO regions and partners to be led by WHO headquarters (HQ). Commit to support and serve as rapporteur for the eventual consultation.
Estimated effort: ~maximum 10 days total | 31-12-2021 |
Specific requirements
WHO/Agenda, Policy and Strategy (APS) is inviting proposals for the execution of the above work by companies or individual consultants.
- Qualifications required:
- Advanced degree (Masters level or above) in Medicine, Epidemiology, Infectious Diseases, Public Health, Global/International Health, Paediatric Health or other fields relevant to immunization.
- Demonstrated understanding of goals, operations and priorities of routine immunization, and the Measles and Rubella Initiative.
- Experience required:
- At least seven years of professional work experience in the health sector with clearly demonstrated experience in working with ministries of health in planning, implementing or monitoring immunization programmes in low-resource environments.
- Demonstrated experience of working with the United Nations system, including WHO country, regional and global offices and UNICEF programme or supply division.
- Expertise in monitoring and evaluation frameworks and/or immunization programme surveillance and monitoring.
- Skills / Technical skills and knowledge:
- Excellent oral and written communication and presentation skills.
- Knowledge of vaccine-preventable diseases and immunization system components.
- Strong interpersonal, negotiating and consultative skills.
- Proven experience to work effectively, cooperatively and strategically to meet short deadlines in a fast environment.
Language requirements:
- Expert knowledge of written and spoken English.
- Working knowledge of French or other WHO official language is an asset.
Essential proposal content
- Cover letter/statement of interest justifying candidature and how the aforementioned requirements are met.
- CVs of proposed project personnel.
- Annotated Budget - separating proposed fees from travel/reimbursable costs - for the various deliverables.
Place of assignment
The applicant will be home-based.
Timeline and Duration
The contract is expected to last until 31 December 2021 and corresponds to a full-time equivalent of 100%. Pay scale will be defined according to the level of expertise of the selected candidate.
Medical clearance
The selected Consultant will be expected to provide a medical certificate of fitness for work.
Application Process
Qualified applicants should submit all proposals, with a length of 3-7 pages - including budget, along with their CV and a cover letter in English, by 25 June 2021 to Dr Crowcroft at email: crowcroftn@who.int.
Applications received after this date will not be accepted.
In the email subject line, please put “Consultancy, MRSF monitoring and evaluation”.
Only successful candidates will be contacted. CVs received from this posting may be used to fill other current and future openings requiring a similar skill set.
Award of contract
The award shall be made to the bidder whose proposal best meets the requirements of the request for proposals in terms of demonstrated expertise, quality and cost. If multiple persons will be involved, all team
members will be required to demonstrate the absence of any conflict of interest.
WHO reserves the right to contact bidders subsequent to submission of proposals and prior to award for clarifications. Revisions may be permitted after submission of a proposal, and prior to award.
WHO reserves the right to reject any or all proposals submitted.
WHO shall not be responsible for any costs incurred by the bidders in preparing, submitting or presenting its proposal.
The contract will be awarded on: 12 July 2021 (at the latest).